Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
08/2005
08/04/2005US20050171096 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
08/04/2005US20050171092 Chemical compounds
08/04/2005US20050171091 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
08/04/2005US20050171083 Modified release pharmaceutical formulation
08/04/2005US20050171078 Cholinergic ligands at the nicotinic acetylcholine receptors; diseases related to the cholinergic system; neurodegenerative disorders; pain; antiinflammatory; diagnostic or monitoring tools using labelled forms; 3-Phenyletynyl-quinuclidin-2-ene
08/04/2005US20050171075 Substitued 19-nor-cholestenes; antineoplastic agents, wound healing agents, antiinflammatory agents; autoimmune diseases, transplant rejection inhibition, hyperplasia, graft versus host disease; increased cell growth modulation and differentiation, low calcemic activity
08/04/2005US20050171070 Stable salts of o-acetylsalicylic acid containing basic amino acids II
08/04/2005US20050171068 Novel 4-dedimethylaminotetracycline derivatives
08/04/2005US20050171057 Pantoprazole cyclodextrin inclusion complexes
08/04/2005US20050171047 Immunostimulatory nucleic acid molecules
08/04/2005US20050170009 Traditional chinese pharmaceutical formulation for treatment of paradentosis, process for preparation and use thereof
08/04/2005US20050169982 Topiramate sodium, topiramate lithium, topiramate potassium, or polymorphs, solvates, hydrates, dehydrates, co-crystals, anhydrous, and amorphous forms; seizures, obesity, neuropathic pain, affective disorders, tobacco cessation, chronic fatigue syndrome, drug addiction; highly soluble, bioavailability
08/04/2005US20050169923 monoclonal antibody prevents the growth or differentiation of the B cell; secreted by the hybridoma; therapy of autoimmune diseases, sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura; biodrug
08/04/2005US20050169913 Administering a monoclonal antibody or enzyme inhibitor of prothrombinase; therapeutic treatment of bacterial and viral infections, allograft and xenograft rejection, cancer, glomerulonephritis, gastrointestinal disorders and fetal loss; inhibiting gene expression of prothrombinase
08/04/2005US20050169853 Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with Porphyromonas gingivalis
08/04/2005US20050166911 preparing raw material liquid so that lactulose content within powder produced following spray drying is 10 to 50% by weight, protein content is 0.2 to 9.0 parts by weight per 1 part by weight of lactulose, and chlorine content is no more than 0.08 parts by weight per 1 part by weight of protein, drying
08/04/2005CA2554588A1 Method of preparing low-crystallinity oltipraz or amorphous oltipraz
08/03/2005EP1559710A2 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV, process for their preparation and their use
08/03/2005EP1559709A1 Heterocycle-containing carboxylic acid derivative and drug containing the same
08/03/2005EP1559446A1 Treating agent for diarrhea-predominant irritable bowel syndrome
08/03/2005EP1559428A1 Receptor regulator
08/03/2005EP1559422A1 Receptor function controlling agent
08/03/2005EP1558566A1 Novel phenylnaphthalene derivatives, method for production thereof and pharmaceutical compositions comprising the same
08/03/2005EP1558288A1 Gastric acid secretion inhibiting composition
08/03/2005EP1558279A1 Oral formulation of botulinum toxin and use thereof for treating peptic ulcers and gastroesophageal reflux disease
08/03/2005EP1558277A1 Treatment of inflammatory bowel disease
08/03/2005EP1558252A2 Substituted furo 2,3-b] pyridine derivatives
08/03/2005EP1438307B1 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist
08/03/2005EP1330455B1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same
08/03/2005EP1280527B1 Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione
08/03/2005EP1267899B1 Ssa inactivated salmonella vaccines
08/03/2005EP1227806B1 Pharmaceutical formulation containing tolterodine and its use
08/03/2005EP1142890B1 Aminopyrazole derivatives
08/03/2005CN1650010A Method for inhibiting the expression of a target gene and medicine for treating tumor disease
08/03/2005CN1650005A Antimicrobial polypeptide and utizliation thereof
08/03/2005CN1649895A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
08/03/2005CN1649884A Novel azacyclic ethynyl derivatives
08/03/2005CN1649878A 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof
08/03/2005CN1649876A 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
08/03/2005CN1649869A Azaindoles as inhibitors of c-Jun N-terminal kinases
08/03/2005CN1649867A Novel 1, 2, 3-substituted indolizine derivatives, inhibitors of FGFs, method for making same and pharmaceutical compositions containing same
08/03/2005CN1649864A Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
08/03/2005CN1649863A Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity
08/03/2005CN1649857A Hydroxamic acid derivatives
08/03/2005CN1649853A Thiazolidinones compound, its preparing method and use as medicine
08/03/2005CN1649849A Tachykinin receptor antagonists
08/03/2005CN1649848A Fused pyrimidines derivatives as antagonists of the corticotropin releasing factor (CRF)
08/03/2005CN1649843A Novel chalcone derivatives and uses thereof
08/03/2005CN1649842A 2, 6-quinolinyl and 2, 6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors
08/03/2005CN1649841A Piperidine derivative compound and drug containing the same compound as active ingredient
08/03/2005CN1649840A Non-peptidic BRS-3 agonists
08/03/2005CN1649819A Novel thyroid receptor ligands
08/03/2005CN1649624A Use of TNF alpha antibodies and another drug
08/03/2005CN1649617A Remedies for liver diseases, hyperlipemia and diabetes
08/03/2005CN1649601A Difructose anhydride-containing composition and use thereof
08/03/2005CN1649597A Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same
08/03/2005CN1649595A Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
08/03/2005CN1649593A Use of 2-alkoxyphenyl-substituted imidazotriazinones
08/03/2005CN1649590A Therapeutic agent comprising lafutidine
08/03/2005CN1649582A Amino-methyl substituted tetracycline compounds
08/03/2005CN1649581A Substituted 3-amino-thieno(2, 3-b)pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
08/03/2005CN1649580A Pharmaceutical composition comprising a lipase inhibitor and glucomannan
08/03/2005CN1649574A Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
08/03/2005CN1649513A Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
08/03/2005CN1648250A Smal linterference ribonucleic acid sequence of hepatitis B virus gene and preparing method
08/03/2005CN1648134A Dog intravenous injection albumin, its preparing method and dog intravenous injection albumin preparation
08/03/2005CN1647819A Use of active enzyme and composition in preventing and treating gastropathy and cosmetics fields
08/03/2005CN1647817A Body building wine and its preparing method
08/03/2005CN1647813A Medicine for treating hepatitis and its preparing method
08/03/2005CN1647812A Chinese medicine composition and its preparing method
08/03/2005CN1647805A Health food having delaying senility and beautifying function and its preparing method
08/03/2005CN1647801A Staphylococcus aureus metabolic product medicine oral preparation and its use
08/03/2005CN1213049C Alkylated imidazopyridine derivatives and medicine containing them and use
08/03/2005CN1213040C Serine protese inhibitors
08/03/2005CN1213029C S-Ht receptor agonist and its preparing method for salt
08/03/2005CN1213028C Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl IV, processes for their preparation, and their use
08/03/2005CN1213025C 硫代酰胺衍生物 Thioamide derivatives
08/03/2005CN1213021C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors
08/03/2005CN1213020C Phenylalaninol derivatives
08/03/2005CN1212860C Cordyceps sinensis buccal tablets
08/03/2005CN1212858C Chinese medicine with four integrated functions for treating hepatic disease
08/03/2005CN1212855C Oral cavity healthy paste
08/03/2005CN1212851C Buccal medicine for treating stomatocase
08/03/2005CN1212843C Egg yolk lecithin soft capsule and its production process
08/03/2005CN1212842C Melazocine masticatory and its preparation
08/03/2005CN1212840C Slow-releasing kurarinol preparation and its preparing method
08/03/2005CN1212837C Micro-pillet preparation of ranitidine
08/03/2005CN1212833C Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same
08/03/2005CN1212831C Pharmaceutical preparations
08/02/2005US6924362 Monoclonal antibodies specific for the E2 glycoprotein of hepatitic C virus and their use in the diagnosis, treatment, and prevention of hepatitis C
08/02/2005US6924314 Compounds for the treatment of metabolic disorders
08/02/2005US6924309 Modulation cystic fibrosis; antiinflammatory agents; antiallergens; rheumatic diseases; autoimmune diseases
08/02/2005US6924305 Diazocine derivatives and their use as tryptase inhibitors
08/02/2005US6924297 Naphathalene derivatives which bind to the EP4 receptor
08/02/2005US6924289 Useful for treating or preventing a disorder or condition selected from hypertension, depression, anxiety, phobias, post trauma stress, sexual disfunction, eating disorder, obesity, Alzheimer's disease, Parkinson's disease etc.
08/02/2005US6924288 Enantiomerically pure opioid diarylmethylpiperzine and methods of using same
08/02/2005US6924278 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases
08/02/2005US6924276 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
08/02/2005US6924266 NTP-peptides and method for removal of tumors
08/02/2005US6923988 Solid carrier includes a hydrophililc surfactant and a drug
1 ... 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 ... 1258